Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 252,880 | 0.2% | 557,713 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 243,505 | 0.2% | 546,956 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 265,150 | 0.3% | 546,904 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 219,619 | 0.2% | 545,366 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 289,384 | 0.3% | 622,225 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 296,969 | 0.3% | 633,575 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 290,862 | 0.3% | 695,825 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 333,163 | 0.2% | 818,803 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 306,535 | 0.2% | 881,505 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 326,719 | 0.2% | 928,417 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 287,434 | 0.2% | 912,286 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 242,296 | 0.2% | 838,863 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 218,257 | 0.2% | 751,883 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 211,043 | 0.1% | 749,795 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 165,934 | 0.1% | 638,594 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 105,341 | 0.1% | 476,920 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 107,558 | 0.1% | 592,967 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 120,723 | 0.1% | 598,740 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 130,773 | 0.1% | 608,555 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 101,320 | 0.1% | 428,708 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 66,744 | 0.1% | 245,276 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 78,916 | 0.1% | 276,726 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 66,544 | 0.1% | 279,654 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 52,833 | 0.1% | 241,299 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 16,544 | 0.0% | 233,929 | 3/31/2014 |
| 2013 Q4 | 5/1/2014 | 16,880 | 0.0% | 227,205 | 12/31/2013 |